Newstral
Financial Times Novartis
- FNovartis wins approval for world’s most expensive drugft.com
- FNovartis to limit M&A spend to 5% of market valueft.com
- FNovartis weighs reinsurance tie-up to fund costly drugsft.com
- FNovartis to acquire Endocyte in $2.1bn dealft.com
- FNovartis joins Pfizer in shelving US price increasesft.com
- FNovartis to spin off $25bn Alcon eyecare businessft.com
- FTop Novartis lawyer quits after payments to Trump aideft.com
- FNovartis draws attention of Swiss prosecutors over Cohen dealft.com
- FNovartis sells stake in consumer unit to GSK for $13bnft.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.